Antares Pharma (ATRS): Q2 EPS of -$0.03 in-line. Revenue of $4.5M (+28.6% Y/Y). (PR)

|About: Antares Pharma Inc. (ATRS)|By:, SA News Editor
Antares Pharma (ATRS): Q2 EPS of -$0.03 in-line. Revenue of $4.5M (+28.6% Y/Y). (PR)